这一变化发生在同一天，此前该公司于6月7日披露的配股增加了公司已发行股本。根据向伦敦证券交易所提交的监管文件，Theobald在N4 Pharma PLC的直接投票权现对应16,981,319股股份。

Investing.com — Alliance Pharma plc已披露，其董事Richard McKenzie计划于2025年4月24日或之后收购公司23,000股股份，占股份总数的0.004%。此举紧随2025年1月10日宣布的Aegros Bidco Limited对Alliance的收购建议，Aegros Bidco Limited将由DBAY Advisors ...

Shares in South Africa's Aspen Pharmacare dropped more than 30% on Wednesday, a day after the company issued a profit warning ...

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going ...

Around 1,000 of these jobs will be within the company with the others in supporting roles, including construction. The ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

In this TRY IT TUESDAY, we're testing the The Pharma-C Company - Odor Eliminator Fabric & Room Spray. Available on Amazon, it ...

The stock’s sentiments have received a significant boost following the approval of the flagship drug Ohtuvayre for the ...

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal ...

The up move in the stock came after the company arm Eugia Pharma Specialities, received final approval from USFDA to ...

One of the company’s subsidiaries, Lupin Diagnostics Limited, has become the first 100 per cent NABL accredited company in ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...